RELIEF THERAPEUTICS N/ CH1251125998 /
2024-11-12 5:31:37 PM | Chg. -0.180 | Volume | Bid9:57:01 PM | Ask9:57:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
6.440CHF | -2.72% | 441,245 Turnover: 3.11 mill. |
-Bid Size: 700 | -Ask Size: 62 | 90.42 mill.CHF | - | - |
Assets
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | .7000 | 2.4000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Intangible Assets | 27.4000 | 23.4000 | 20.8000 | 30.8000 | 30.8000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 28.2000 | 25.9000 | 20.8000 | 30.8000 | 30.8000 | ||||||
Inventories | 2.2000 | .5000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Accounts Receivable | 3.5000 | 3.1000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Cash and Cash Equivalents | .8000 | 4.2000 | .3000 | .4000 | .1000 | ||||||
Current Assets | 10 | 8.7000 | 7.1000 | .6000 | .2000 | ||||||
Total Assets | 38.2000 | 34.6000 | 27.9000 | 31.4000 | 31 |
Liabilities
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 6.2000 | 3.9000 | .4000 | .4000 | .5000 | ||||||
Long-term debt | 3.7000 | 1.4000 | 1.9000 | - | - | ||||||
Liabilities to Banks | 8 | 4.5000 | 4.2000 | 0.0000 | 0.0000 | ||||||
Provisions | 1.4000 | 1.2000 | .7000 | 6.5000 | 7.5000 | ||||||
Liabilities | 21.4000 | 12.7000 | 11.5000 | 9.2000 | 10 | ||||||
Share Capital | 3.2000 | 5.4000 | 5.4000 | 19.5000 | 20.1000 | ||||||
Total Equity | 16.4000 | 21.9000 | 16.3000 | 22.2000 | 20.9000 | ||||||
Minority Interests | .4000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 38.2000 | 34.6000 | 27.9000 | 31.4000 | 31 |
Income Statement
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 16.9000 | 16.2000 | .2000 | 0.0000 | 0.0000 | ||||||
Depreciation (total) | 1.7000 | 5.2000 | .3000 | 14.5000 | - | ||||||
Operating Result | -9.4000 | -10.1000 | -3.5000 | -16.5000 | -1.7000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -10.2000 | -10.4000 | -4 | -16.8000 | -1.9000 | ||||||
Income Taxes | .2000 | .2000 | 0.0000 | 0.0000 | -1 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -10 | -10.2000 | -8.5000 | -16.8000 | -2.9000 |
Per Share
Cash Flow
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -7.2000 | -7.3000 | -6.2000 | -2.9000 | -1.2000 | ||||||
Cash Flow from Investing Activities | -.8000 | -.5000 | 1 | .1000 | 0.0000 | ||||||
Cash Flow from Financing | 7.8000 | 11.2000 | 2.1000 | 3.1000 | .9000 | ||||||
Decrease / Increase in Cash | 0.0000 | 3.4000 | -3 | .4000 | -.3000 | ||||||
Employees | - | - | - | - | - |